Delivery Order SPE2DB22D6029-SPE2DB25FLTRU
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,686.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order to provide ORILISSA 150 MG TABLET 7S, a specialty medication. The contract has an ultimate completion date of October 23, 2024 and is a firm fixed-price agreement. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $7,144.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product, with a completion date of December 10, 2024. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,806.89 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,488.95 firm fixed-price delivery order is for the supply of ORILISSA 200 MG TABLET 14S, a pharmaceutical product. The contract has an ultimate completion date of December 20, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORILISSA 200 MG TABLET 14S. The $3,231.16 firm-fixed-price contract has an ultimate completion date of July 28, 2023.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $2,635.47, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for the supply of a wide range of pharmaceutical and medical products to support military treatment programs and facilities worldwide.
The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ORILISSA 150 mg tablets. The fixed-price contract is valued at $10,740.60 and has an ultimate completion date of September 9, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies for the provision of a wide range of pharmaceutical and medical products. These IDCs, valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ORILISSA 150 MG TABLET 7S. The contract is a firm-fixed-price delivery order with a ceiling value of $6,547.78 and a period of performance through August 16, 2024. Amerisourcebergen Drug Corp's Corporate Office division is the awardee. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award for $5,397.56 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical.
The contract is for the delivery of ORILISSA 200 MG TABLET 14S, a pharmaceutical product, with a performance period ending on September 3, 2024. As one of the largest...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $5,888.82 contract is for the supply of the drug Orilissa 150 mg tablets. The award has a maximum completion date of March 12, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by...